Detailed price information for Abbvie Inc (ABBV-N) from The Globe and Mail including charting and trades.
Becton Dickinson has delivered a strong share price run over the past year, which puts fresh focus on whether the current US$200.42 level is grounded in the cash it can generate. For anyone looking at the stock today, the central issue is how that recent performance lines up with the cash flow profile implied by its existing business. The share price return of 40.1% over the past year puts real pressure on the question of whether the valuation still lines up with the cash the business can...
Becton, Dickinson and Company stock surged 26% in 4 months as fundamentals rebounded; now near fair value at 15x P/E, rated HOLD. Click for more on BDX stock.
This is the newest page. Registered accounts read further back.